NDC 17856-2170-01 - Acyclovir suspension
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-2170
- Requested NDC
- 17856-2170-01
- Package NDCs from labels
- 17856-2170-1, 17856-2170-2, 17856-2170-01
- Manufacturer
- Atlantic Biologicals Corp.
- Effective date
- 2026-05-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir Oral Suspension, USP | Atlantic Biologicals Corp. | 2026-05-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-2170-1 | Acyclovir suspension | 72 in 1 CASE | SUSPENSION | 72 | 1 | |
| 17856-2170-1 | Acyclovir suspension | 5 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 5 | 1 | |
| 17856-2170-2 | Acyclovir suspension | 10 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 10 | 1 | |
| 17856-2170-2 | Acyclovir suspension | 72 in 1 CASE | SUSPENSION | 72 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | PDC6A3C0OX |
| Acyclovir | ACYCLOVIR | Redpharm Drug | 37453bcd-e34e-5902-e063-6294a90a0245 | 2025-12-13 | Warnings, Adverse reactions | X4HES1O11F |
| ElixirLidoFast Rapid Relief | GLYCERIN, LIDOCAINE, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | ELIXIR HEALTHCARE USA, LLC. | 45de9dfa-6c89-1eae-e063-6294a90a4dac | 2025-12-13 | Warnings | PDC6A3C0OX |
| Kroger Hemorrhoid | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Kroger Company | 45b2dd86-7fb0-07bf-e063-6394a90a1884 | 2025-12-11 | Warnings | PDC6A3C0OX |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| Acyclovir | ACYCLOVIR | Chartwell RX, LLC | 8cd22728-34b4-4e55-8339-580138fe46d8 | 2025-12-09 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Cadila Pharmaceuticals Limited | acef88f4-6456-4092-993f-27e1496097c7 | 2025-12-05 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Aurobindo Pharma Limited | 37761c4f-4378-472e-a41b-6a1d40575cb7 | 2025-12-03 | Warnings, Adverse reactions | 307730 X4HES1O11F |
| acyclovir | ACYCLOVIR | Viona Pharmaceuticals Inc | e580b7e9-9060-43f5-9b58-33998078d7e4 | 2025-12-02 | Warnings, Adverse reactions | X4HES1O11F |
| BUDDATE INONOTUS OBLIQUUS WATER BRILLIANCE MASK | BUTYLENE GLYCOL, GLYCERIN, INONOTUS OBLIQUUS (MUSHROOM) EXTRACT | BUDDATE Co Ltd | 464988ad-557e-13f5-e054-00144ff8d46c | 2025-11-30 | Warnings | PDC6A3C0OX |
| BUDDATE LOTUS MOISTURE ESSENCE | GLYCERIN, NIACINAMIDE, NELUMBO NUCIFERA FLOWER EXTRACT, PORTULACA OLERACEA EXTRACT | BUDDATE Co Ltd | 46499995-8b13-3e5c-e054-00144ff88e88 | 2025-11-30 | Warnings | PDC6A3C0OX |
| Acyclovir | ACYCLOVIR | Advagen Pharma Limited | 6a9ea291-4ad5-48a8-8c08-5a17c8757549 | 2025-11-27 | Warnings, Adverse reactions | 307730 X4HES1O11F |
| acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | 8d9fea43-6c04-40d7-8aac-398c2de2a558 | 2025-11-27 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Zydus Pharmaceuticals (USA) Inc. | edb0cd28-ee57-4b60-be94-62c797fbf5e6 | 2025-11-27 | Warnings, Adverse reactions | X4HES1O11F |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.